DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties-Reference-Cited by-同舟云学术

DPS-2: A Novel Dual MEK/ERK and PI3K/AKT Pathway Inhibitor with Powerful Ex Vivo and In Vivo Anticancer Properties

Published:2019-07 Issue:7 Volume:12 Page:932-950
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Goulielmaki Maria,Assimomytis Nikos,Rozanc Jan,Taki Eleni,Christodoulou Ioannis,Alexopoulos Leonidas G.,Zoumpourlis Vassilis,Pintzas Alexandros,Papahatjis Demetris

Funder

Greece and the European Regional Development Fund of the European Union

O.P. Competitiveness, Entrepreneurship and Innovation

Regional Operational Program of Attica

EU Horizon 2020-Mel-Plex

HFRI PhD Fellowship

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference52 articles.

1. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention;Colussi;Int J Mol Sci,2013

2. Genetic prognostic and predictive markers in colorectal cancer;Walther;Nat Rev Cancer,2009

3. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability;Thorstensen;Neoplasia,2005

4. Correlation between gene variants, signaling pathways, and efficacy of chemotherapy drugs against colon cancers;Tripathi;Cancer Informat,2016

5. Targeting the RAF-MEK-ERK pathway in cancer therapy;Montagut;Cancer Lett,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the ERK1/2 MAPK Cascade;Biomolecules;2023-10-20

2. Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo;PLOS ONE;2023-03-23

3. MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives;RSC Medicinal Chemistry;2023

4. In silico high throughput screening and in vitro validation of a novel Raf/Mek dual inhibitor against colorectal carcinoma;Biologia;2022-08-02

5. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways;Chemico-Biological Interactions;2022-05